Congratulations to Dr. Charles Maponga on his election to the AIDS Clinical Trials Group (ACTG) Hepatitis Transformative Science Group (TSG).

 

Congratulations to Dr. Charles Maponga on his election to the AIDS Clinical Trials Group (ACTG) Hepatitis Transformative Science Group (TSG). In his committee role of Investigator, Dr. Maponga will represent the Parirenyatwa Clinical Research site in Harare, Zimbabwe. The Hepatitis TSG works to provide effective therapy to all people with HIV co-infected with viral hepatitis and to provide a platform for conduct of novel DAA trials in patients with HCV. The mission of the ACTG Network is to reduce the burden of disease due to HIV, tuberculosis, and viral hepatitis.